Fly News Breaks for February 13, 2020
Feb 13, 2020 | 09:29 EDT
DA Davidson analyst Linda Weiser lowered her price target on Nu Skin to $35 after its in-line Q4 EPS and the 28% decline in its constant currency sales in China. The analyst notes that the company has suspended meetings in that market due to the coronavirus outbreak, driving its "big" expected 2020 earnings declines with no growth until Q4. Weiser adds that while Nu Skin's free cash flow may be below dividends, a payout cut is "highly unlikely" as she lowers the target valuation on the stock to 5.5-times from 6.0-times enterprise value to expected EBITDA.
News For NUS From the Last 2 Days
There are no results for your query NUS